Dr. Ryan Michael Trowbridge, MD

Dr. Trowbridge practices at CHI Alegent Health Physical Therapy Clinic Bergan - Unit in Omaha, Nebraska.

Dr. Trowbridge's NPI, 1770996191, was assigned on June 3, 2014. Dr. Trowbridge graduated from Creighton University School of Medicine in 2014. Dr. Trowbridge holds Nebraska license 30784.

Dr. Trowbridge's primary practice is CHI Alegent Health Physical Therapy Clinic Bergan - Unit, at 7710 Mercy Rd, Omaha, NE 68124.

Dr. Trowbridge's primary practice is CHI Alegent Health Physical Therapy Clinic Bergan - Unit in Omaha, Nebraska. Dr. Trowbridge is also affiliated with CHI Health Creighton University Medical Center - Bergan Mercy. The medical group on file is CHI Health Clinic. Dmand AI also links Dr. Trowbridge to 1 more group practice or clinic and 1 hospital outpatient department, each named with a free account. Dr. Trowbridge's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Trowbridge practices, 4 sites in all. Vendor and product names are available with a free account.

Dermatology is Dr. Trowbridge's primary specialty in the NPI Registry, under taxonomy code 207N00000X. Dr. Trowbridge is licensed in Nebraska.

CMS data shows 1,636 Medicare services from Dr. Trowbridge across 22 procedure codes in 2024, for 422 Medicare patients. Medicare paid $136,931 for them. Every service was in an office.

CMS counts 422 Medicare patients who saw Dr. Trowbridge in 2024. The largest group is 65 to 74, with 222 patients. 74% of them have high cholesterol, and 71% have high blood pressure. 5% are also on Medicaid. Their average risk score is 0.97, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Trowbridge's median patient age at 62, with 46% women.

In 2024, Dr. Trowbridge wrote 653 Medicare Part D claims for 222 patients. 85% of them were for generic drugs. CMS names the drug for 549 of them, across 24 drugs with 11 or more claims each, at $657,852 in total drug cost. In 2023, CMS named 358 claims across 13 drugs.

Dr. Trowbridge accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 52 procedures of melanoma (skin cancer) excision by Dr. Trowbridge, more than 87% of the clinicians it reports for that procedure.

Removal of nail tissue: 1 to 10 procedures (CMS shows small counts as a range)

Removal or shaving of skin growth: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 19 papers to Dr. Trowbridge, published from 2012 to 2024. 2013 was the busiest year, with 4. The most frequent topics are Receptors, Calcitriol, Adenocarcinoma and Dermatologic Agents. Dr. Trowbridge has published most often in Exp Mol Pathol. Dr. Trowbridge's most frequent co-authors are Dillon Daniel Clarey, MD, Sumeet K. Mittal, MD and Mark R. Pittelkow, MD.

CMS Open Payments shows 393 general payments to Dr. Trowbridge from 34 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 92% of the total. Janssen Pharmaceuticals, Inc paid the most, $1,252.

Dr. Trowbridge graduated from Creighton University School of Medicine in 2014.